This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015;23(6):587–602.AhadAAl-JenoobiFIAl-MohizeaAMAkhtarNRaishMAqilMSystemic delivery of β-blockers via transdermal route for hypertension201523658760210.1016/j.jsps.2013.12.019Search in Google Scholar
Aqil M, Sultana Y, Ali A. Transdermal delivery of β-blockers. Expert Opin Drug Deliv. 2006;3(3):405–18.AqilMSultanaYAliATransdermal delivery of β-blockers2006334051810.1517/17425247.3.3.405Search in Google Scholar
Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91(9):2076–89.AroraPMukherjeeBDesign, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt200291920768910.1002/jps.10200Search in Google Scholar
Calatayud-Pascual MA, Sebastian-Morelló M, Balaguer-Fernández C, Delgado-Charro MB, López-Castellano A, Merino V. Influence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol: Evaluation by dermatopharmacokinetics. Pharmaceutics. 2018;10(4).Calatayud-PascualMASebastian-MorellóMBalaguer-FernándezCDelgado-CharroMBLópez-CastellanoAMerinoVInfluence of chemical enhancers and iontophoresis on the in vitro transdermal permeation of propranolol: Evaluation by dermatopharmacokinetics201810410.3390/pharmaceutics10040265Search in Google Scholar
Costa P, Sousa Lobo JM. Modeling and Comparison of Dissolution Profiles. Eur J Pharm Sci. 2001;13(2):123–133.CostaPSousa LoboJMModeling and Comparison of Dissolution Profiles200113212313310.1016/S0928-0987(01)00095-1Search in Google Scholar
Dey BK, Kar PK, Nath LK. Formulation design, preparation and in vitro – in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex. Research J. Pharm. and Tech. 2009;2(1):155–160.DeyBKKarPKNathLKFormulation design, preparation and in vitro – in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex200921155160Search in Google Scholar
European pharmacopoeia 10.4. 2.9.4. Dissolution test for transdermal patches. (https://pheur.edqm.eu/app/10-4/content/10-4/20904E.htm?highlight=on&terms=dissolution). Revised April 2021. Accessed June 7, 2021.(https://pheur.edqm.eu/app/10-4/content/10-4/20904E.htm?highlight=on&terms=dissolution). Revised April 2021. Accessed June 7, 2021.Search in Google Scholar
Levis SR, Deasy PB. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int J Pharm. 2003;253(1–2):145–57.LevisSRDeasyPBUse of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride20032531–21455710.1016/S0378-5173(02)00702-0Search in Google Scholar
Sanap GS, Dama GY, Hande AS et al. Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharm. 2008;2(2):129.SanapGSDamaGYHandeASPreparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer20082212910.4103/0973-8258.41189Search in Google Scholar